IRIS
ALBANESE, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.217
AS - Asia 2.573
EU - Europa 1.761
SA - Sud America 323
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 18.928
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.160
SG - Singapore 1.484
IT - Italia 431
CN - Cina 418
RU - Federazione Russa 298
BR - Brasile 272
DE - Germania 226
VN - Vietnam 188
UA - Ucraina 180
HK - Hong Kong 176
IE - Irlanda 139
FR - Francia 123
GB - Regno Unito 95
JP - Giappone 95
FI - Finlandia 74
KR - Corea 61
PL - Polonia 60
SE - Svezia 33
IN - India 29
NL - Olanda 27
CA - Canada 25
AR - Argentina 23
ES - Italia 17
ID - Indonesia 17
MX - Messico 17
ZA - Sudafrica 14
IQ - Iraq 12
BD - Bangladesh 11
BE - Belgio 10
TR - Turchia 10
UZ - Uzbekistan 10
EC - Ecuador 9
MA - Marocco 9
AT - Austria 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
PH - Filippine 7
TN - Tunisia 7
AU - Australia 6
EG - Egitto 6
JM - Giamaica 6
EU - Europa 5
GR - Grecia 5
JO - Giordania 5
RS - Serbia 5
SA - Arabia Saudita 5
TW - Taiwan 5
AL - Albania 4
CH - Svizzera 4
CL - Cile 4
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
PY - Paraguay 4
CO - Colombia 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
QA - Qatar 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 18.928
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.638
Wilmington 3.335
Houston 3.009
Singapore 560
Fairfield 477
San Jose 395
Ashburn 340
Ann Arbor 280
Chandler 220
Council Bluffs 200
Seattle 192
Cambridge 178
Hong Kong 174
Beijing 159
Jacksonville 142
Dublin 136
Rome 128
New York 116
Colorado Springs 110
Medford 102
Tokyo 88
The Dalles 84
Santa Clara 71
Ho Chi Minh City 68
Los Angeles 67
Lawrence 47
Moscow 46
Kraków 45
Hanoi 41
Lauterbourg 41
Buffalo 37
Zhengzhou 34
Helsinki 33
Dearborn 32
Milan 32
São Paulo 31
Dallas 29
San Diego 28
Menlo Park 25
Norwalk 22
Chicago 19
North Bergen 18
Nuremberg 18
Redwood City 18
Atlanta 17
London 17
Salt Lake City 13
Brooklyn 11
Jakarta 11
Orem 11
Phoenix 11
Redondo Beach 11
Rio de Janeiro 11
Brussels 10
Shanghai 10
Tampa 10
Warsaw 10
Boardman 9
Elk Grove Village 9
Guangzhou 9
Johannesburg 9
Lappeenranta 9
Naples 9
Boston 8
Columbus 8
Frankfurt am Main 8
Haiphong 8
University Park 8
Verona 8
Amsterdam 7
Manchester 7
Miami 7
Munich 7
San Francisco 7
Tashkent 7
Turin 7
Belo Horizonte 6
Hefei 6
Palermo 6
Palo Alto 6
Paris 6
Philadelphia 6
Roebling 6
Seoul 6
Sterling 6
Stockholm 6
Amman 5
Charlotte 5
City of London 5
Creede 5
Curitiba 5
Da Nang 5
Erbil 5
Fortaleza 5
Gavirate 5
Istanbul 5
Madrid 5
Mexico City 5
Monte Porzio Catone 5
Montes Claros 5
Totale 15.299
Salva come PNG Salva come JPEG
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 622
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 580
Increased cortical excitability after selective REM sleep deprivation in healthy humans: a transcranial magnetic stimulation study 574
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 515
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 503
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 503
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 498
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 483
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 482
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 472
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 467
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 454
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 448
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 446
May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis 445
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 439
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 434
Facial diplegia resembling bilateral Ramsay Hunt Syndrome 430
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 429
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 428
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 415
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 408
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 390
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 390
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 390
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 390
Electroencephalography and dementia: a literature review and future perspectives 387
Restless legs syndrome and post polio syndrome: a case-control study 387
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 383
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 366
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report 364
Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study 354
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 345
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 318
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 258
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 252
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 230
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 201
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction 193
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study 179
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study 165
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 161
Functional assessment of outer and middle macular layers in multiple sclerosis 147
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 118
Distortion product otoacoustic emissions and their suppression as predictors of peripheral auditory damage in migraine: a case-control study 107
Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis 105
Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study 100
Poor Adherence to the Mediterranean Diet and Sleep Disturbances Are Associated with Migraine Chronification and Disability among an Adult Population in the Lazio Region, Italy 94
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients 93
Fampridine improves acute optic neuritis contributing to a long-lasting recovery of nerve function 90
Correlation between endometriosis and migraine features: Results from a prospective case-control study 85
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway 85
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 85
Subclinical cochlear dysfunction in newly diagnosed relapsing-remitting multiple sclerosis 81
Link between gut microbiota dysbiosis and chronic kidney disease 79
Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography 64
Linking migraine to gut dysbiosis and chronic non-communicable diseases 58
One-month atogepant treatment induces rapid changes in delta-band functional connectivity in migraine: an HD-EEG study 54
REPLY to "Comment on Correlation between endometriosis and migraine features: Results from a prospective case-control study'': correlation between endometriosis and migraine features is not based on a broad strokes results 54
Evaluating the impact of anti-CGRP monoclonal antibodies on retinal features in migraine patients: a retrospective optical coherence tomography study 47
Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies 44
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports 40
Early effect of onabotulinumtoxinA on EEG-based functional connectivity in patients with chronic migraine: A pilot study 38
Inflammatory cytokine signatures are associated with disease burden and comorbidity of episodic migraine and endometriosis 38
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study 37
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures 36
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 35
Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 35
Unexpected genomic architecture in a sporadic case of C1-INH Hereditary Angioedema: the hidden heritability 34
Gut-oriented interventions in patients with multiple sclerosis: fact or fiction? 33
Acupuncture Versus Standard Medical Care in the Prophylactic Treatment of Migraine: A Systematic Review and Meta-Analysis 32
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) 29
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 28
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study) 28
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance 28
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 28
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 28
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 27
Evaluation of the retinal vascular and structural changes in migraine patients treated with anti-CGRP monoclonal antibodies 27
Clinical Management of migraine 26
Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment 26
Variable Ophthalmologic Phenotypes Associated with Biallelic Loss-of-Function Variants in POMGNT1 26
Correlation between epileptiform activity and cerebrospinal fluid biomarkers in Alzheimer's disease 25
In Alzheimer's disease sleep impairment is correlated with cognitive decline, increased tau and decreased beta-amyloid CSF levels 25
Alzheimer disease: sleep, orexin and cognitive decline 24
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: Friend (fremanezumab in real world study), the first Italian multicenter, prospective real-life study 24
Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence 22
Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter Prospective Observational Study 22
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 21
Maintenance of response and predictive factors of one-year GalcanezumAb treatment in Real Life migraine patients in ITaly: the multicenter prospective cohort GARLIT study 21
Serum vitamin D levels are reduced in obstructive sleep apnea patients and increase after continuous positive airway pressure therapy 20
Medication overuse and drug addiction: a narrative review from addiction perspective 20
Reward-Economic Choices-Decision Making and Dopamine 20
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 19
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 19
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 18
Narrative Medicine to integrate patients', caregivers' and clinicians' migraine experiences: the DRONE multicentre project 18
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) 17
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 17
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 17
Totale 19.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 97 25
2021/2022493 31 22 18 9 40 52 17 22 55 62 18 147
2022/2023665 67 53 51 83 50 136 77 52 54 10 17 15
2023/2024245 38 6 14 8 17 51 11 8 5 27 12 48
2024/20251.989 43 236 128 90 24 230 111 77 113 198 417 322
2025/20263.525 176 108 301 212 204 87 845 502 508 532 50 0
Totale 19.319